McNerney ME - Search Results

1

CRISPR screening in human hematopoietic stem and progenitor cells reveals an enrichment for tumor suppressor genes within chromosome 7 commonly deleted regions.

Baeten JT, Liu W, Preddy IC, Zhou N, McNerney ME. Baeten JT, et al. Among authors: mcnerney me. Leukemia. 2022 May;36(5):1421-1425. doi: 10.1038/s41375-021-01491-z. Epub 2022 Jan 17. Leukemia. 2022. PMID: 35034954 Free PMC article.

2

Genomic studies controvert the existence of the CUX1 p75 isoform.

Krishnan M, Senagolage MD, Baeten JT, Wolfgeher DJ, Khan S, Kron SJ, McNerney ME. Krishnan M, et al. Among authors: mcnerney me. Sci Rep. 2022 Jan 7;12(1):151. doi: 10.1038/s41598-021-03930-4. Sci Rep. 2022. PMID: 34997000 Free PMC article.

3

CUX1 is a haploinsufficient tumor suppressor gene on chromosome 7 frequently inactivated in acute myeloid leukemia.

McNerney ME, Brown CD, Wang X, Bartom ET, Karmakar S, Bandlamudi C, Yu S, Ko J, Sandall BP, Stricker T, Anastasi J, Grossman RL, Cunningham JM, Le Beau MM, White KP. McNerney ME, et al. Blood. 2013 Feb 7;121(6):975-83. doi: 10.1182/blood-2012-04-426965. Epub 2012 Dec 3. Blood. 2013. PMID: 23212519 Free PMC article.

4

The Harmful Consequences of Increased Fitness in Hematopoietic Stem Cells.

McNerney ME, Le Beau MM. McNerney ME, et al. Cell Stem Cell. 2018 Nov 1;23(5):634-635. doi: 10.1016/j.stem.2018.10.003. Cell Stem Cell. 2018. PMID: 30388419 Free article.

5

The significance of CUX1 and chromosome 7 in myeloid malignancies.

Jotte MRM, McNerney ME. Jotte MRM, et al. Among authors: mcnerney me. Curr Opin Hematol. 2022 Mar 1;29(2):92-102. doi: 10.1097/MOH.0000000000000699. Curr Opin Hematol. 2022. PMID: 35084368 Free PMC article. Review.

6

Dominant role of oncogene dosage and absence of tumor suppressor activity in Nras-driven hematopoietic transformation.

Xu J, Haigis KM, Firestone AJ, McNerney ME, Li Q, Davis E, Chen SC, Nakitandwe J, Downing J, Jacks T, Le Beau MM, Shannon K. Xu J, et al. Among authors: mcnerney me. Cancer Discov. 2013 Sep;3(9):993-1001. doi: 10.1158/2159-8290.CD-13-0096. Epub 2013 Jun 3. Cancer Discov. 2013. PMID: 23733505 Free PMC article.

7

Cytotoxic Therapy-Induced Effects on Both Hematopoietic and Marrow Stromal Cells Promotes Therapy-Related Myeloid Neoplasms.

Stoddart A, Wang J, Fernald AA, Davis EM, Johnson CR, Hu C, Cheng JX, McNerney ME, Le Beau MM. Stoddart A, et al. Among authors: mcnerney me. Blood Cancer Discov. 2020 Jul;1(1):32-47. doi: 10.1158/2643-3230.BCD-19-0028. Blood Cancer Discov. 2020. PMID: 32924016 Free PMC article.

8

EGR1 Haploinsufficiency Confers a Fitness Advantage to Hematopoietic Stem Cells Following Chemotherapy.

Stoddart A, Fernald AA, Davis EM, McNerney ME, Le Beau MM. Stoddart A, et al. Among authors: mcnerney me. Exp Hematol. 2022 Nov;115:54-67. doi: 10.1016/j.exphem.2022.08.003. Epub 2022 Aug 20. Exp Hematol. 2022. PMID: 35995095 Free PMC article.

9

The spectrum of somatic mutations in high-risk acute myeloid leukaemia with -7/del(7q).

McNerney ME, Brown CD, Peterson AL, Banerjee M, Larson RA, Anastasi J, Le Beau MM, White KP. McNerney ME, et al. Br J Haematol. 2014 Aug;166(4):550-6. doi: 10.1111/bjh.12964. Epub 2014 Jun 13. Br J Haematol. 2014. PMID: 24931631 Free PMC article.

10

Nfkb1 is a haploinsufficient DNA damage-specific tumor suppressor.

Voce DJ, Schmitt AM, Uppal A, McNerney ME, Bernal GM, Cahill KE, Wahlstrom JS, Nassiri A, Yu X, Crawley CD, White KP, Onel K, Weichselbaum RR, Yamini B. Voce DJ, et al. Among authors: mcnerney me. Oncogene. 2015 May 21;34(21):2807-13. doi: 10.1038/onc.2014.211. Epub 2014 Jul 21. Oncogene. 2015. PMID: 25043302 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

55 results

Search Page